These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1667104)

  • 1. [A comparative evaluation of the pathogenicity factors of Pseudomonas aeruginosa].
    Komzolova NB
    Gig Sanit; 1991 Nov; (11):68-9. PubMed ID: 1667104
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracellular enzymes of fecal strains of Pseudomonas aeruginosa.
    Marne C; Vindel A
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):307-9. PubMed ID: 2839341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains.
    Chifiriuc MC; Diţu LM; Banu O; Bleotu C; Drăcea O; Bucur M; Larion C; Israil AM; Lazăr V
    Roum Arch Microbiol Immunol; 2009; 68(1):27-33. PubMed ID: 19507624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental infection with Pseudomonas aeruginosa in mice. I. The virulence of Pseudomonas aeruginosa for mice.
    Kobayashi F
    Jpn J Microbiol; 1971 Jul; 15(4):295-300. PubMed ID: 4330067
    [No Abstract]   [Full Text] [Related]  

  • 5. [The cytopathic effect induced by strains of Pseudomonas aeruginosa producing hemolysin, leukocidin and proteases in Hep-2 cells].
    Zanetti S; Cappuccinelli P; Fadda G
    Boll Ist Sieroter Milan; 1986; 65(3):237-41. PubMed ID: 3096348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of potential virulence markers in Pseudomonas aeruginosa isolated from drinking water.
    Silva ME; Filho IC; Endo EH; Nakamura CV; Ueda-Nakamura T; Filho BP
    Antonie Van Leeuwenhoek; 2008 May; 93(4):323-34. PubMed ID: 18038252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Virulence and toxigenicity of Pseudomonas aeruginosa cultures of various origins].
    Dziubak ST
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):50-3. PubMed ID: 6422682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudomonas aeruginosa toxoid].
    Ianishevskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):27-32. PubMed ID: 3922181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pseudomonas aeruginosa and the hydrosphere. Surface waters].
    Kalniia Gp; Komzolova NB
    Gig Sanit; 1985 Dec; (12):53-9. PubMed ID: 3937769
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative evaluation of selective media for studying waste fluids for Pseudomonas aeruginosa].
    Komzolova NB
    Gig Sanit; 1983 Aug; (8):45-7. PubMed ID: 6414891
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enzymes of virulence of several pyogenic bacteria].
    Mel'nikov NI; Kuznetsova LV; Kondratiuk LN; Zhukova EG
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):47-50. PubMed ID: 4240994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pseudomonas aeruginosa in water. Its hygiene and epidemiology].
    Komzolova NB; Kalina GP
    Gig Sanit; 1986 Feb; (2):57-61. PubMed ID: 3082721
    [No Abstract]   [Full Text] [Related]  

  • 13. [Death cases in newborns caused by ps. aeruginosa contaminated drinking-water].
    Weber G; Werner HP; Matschnigg H
    Zentralbl Bakteriol Orig; 1971; 216(2):210-4. PubMed ID: 4994625
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenicity factors in Pseudomonas aeruginosa (proceedings)].
    Scharmann W
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):20-5. PubMed ID: 824891
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the detection of Pseudomonas aeruginosa in water].
    Ziegert E; Stelzer W
    Zentralbl Mikrobiol; 1986; 141(2):121-8. PubMed ID: 3088871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment of Pseudomonas aeruginosa in water.
    Mena KD; Gerba CP
    Rev Environ Contam Toxicol; 2009; 201():71-115. PubMed ID: 19484589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of clinical isolates of Pseudomonas aeruginosa. I. Resistance to serum bactericidal effect and production of proteolytic enzymes.
    Pajdak E; Szkarłat A; Kobylarz K
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):309-14. PubMed ID: 2129385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.
    Homma JY
    Jpn J Exp Med; 1980 Jun; 50(3):149-65. PubMed ID: 6776324
    [No Abstract]   [Full Text] [Related]  

  • 19. Necrotizing fasciitis due to Pseudomonas aeruginosa in immuno-compromised children.
    Abbo O; Accadbled F; Guitard J; Galinier P; Plat-Willson G; Rubie H; Neven B
    Pediatr Blood Cancer; 2010 Jul; 55(1):213-4. PubMed ID: 20486189
    [No Abstract]   [Full Text] [Related]  

  • 20. GROWTH, TOXIGENICITY AND VIRULENCE OF PSEUDOMONAS AERUGINOSA.
    LIU PV; MERCER CB
    J Hyg (Lond); 1963 Dec; 61(4):485-91. PubMed ID: 14099026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.